Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass Balance of 14C-AB1010 in Healthy Males
NCT05200169Phase 1Completed
- Sponsor
- AB Science
- Start
- Jul 2017
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of masitinib, sponsored by AB Science. Primary endpoint: Radioactivity recovery at 168 hours. Started Jul 2017; status: completed.
02
Drugs
masitinib
Beyond the preview
Go deeper on NCT05200169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05200169.